TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9645459

Group type: EXPERIMENTAL
Intervention: Intrahepatic arterial infusion of 131I-radiolabelled anti-HCC monoclonal antibody (Hepama-1 mAb)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Intrahepatic-arterial chemotherapy (non-RIT group)
Number of subjects: 65
Study: 8194689

Group type: EXPERIMENTAL
Intervention: CCK-33 infusion
Number of subjects: 32

Group type: COMPARATOR
Intervention: Saline infusion (Control)
Number of subjects: 32
Study: 3364667

Group type: EXPERIMENTAL
Intervention: MAC 0.5 N2O
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: MAC 1.0 with volatile anesthetic/N2O
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: MAC 0.5 with halothane, enflurane, isoflurane
Number of subjects: 17
Study: 29436374

Group type: EXPERIMENTAL
Intervention: Acupuncture (ACP) - 12 sessions of acupuncture
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Acupuncture + Kinesio Taping (ACP-KT) - 12 sessions of acupuncture plus KT
Number of subjects: 16
Study: 27374309

Group type: EXPERIMENTAL
Intervention: Perindopril 8 mg once daily
Number of subjects: 256

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 256
Study: 24855155

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 5145

Group type: COMPARATOR
Intervention: Diabetes support and education (DSE)
Number of subjects: 5145
Study: 22383407

Group type: EXPERIMENTAL
Intervention: Active learning project on molecular physiology of sins
Number of subjects: 18
Study: 20356615

Group type: EXPERIMENTAL
Intervention: Preperitoneal herniorrhaphy
Number of subjects: 85

Group type: COMPARATOR
Intervention: Mesh plug herniorrhaphy
Number of subjects: 85
Study: 18333862

Group type: EXPERIMENTAL
Intervention: Maraviroc (300 mg b.i.d.)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Maraviroc (100 mg b.i.d.)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 14988451

Group type: EXPERIMENTAL
Intervention: High-protein diet (30% energy)
Number of subjects: 20

Group type: COMPARATOR
Intervention: High-carbohydrate diet (60% energy)
Number of subjects: 20
Study: 11746081

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 9771399

Group type: EXPERIMENTAL
Intervention: Atropine (15 micrograms/kg bolus intravenously, 4 micrograms/kg/h infusion)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 15
Study: 7825028

Group type: EXPERIMENTAL
Intervention: Handpumps maintained by women
Number of subjects: 30

Group type: COMPARATOR
Intervention: Handpumps maintained by project workers
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Latrines supervised by women
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Latrines fenced by women
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Latrines emptied by women
Number of subjects: 30
Study: 2891886

Group type: EXPERIMENTAL
Intervention: Acyclovir or vidarabine treatment for HSV-1 encephalitis
Number of subjects: 24

Group type: COMPARATOR
Intervention: Acyclovir or vidarabine treatment for HSV-2 encephalitis
Number of subjects: 24
Study: 28732147

Group type: COMPARATOR
Intervention: Attention Control
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Telephonic Health Coaching (THC)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Financial Incentives (FI)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Telephonic Health Coaching + Financial Incentives (THC + FI)
Number of subjects: 202
Study: 28437675

Group type: EXPERIMENTAL
Intervention: miR-3135b
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: miR-126-5p
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: miR-142-5p
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: miR-144-5p
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: miR-28-3p
Number of subjects: 199
Study: 26628527

Group type: EXPERIMENTAL
Intervention: IVIG plus cyclosporin A (CsA) (5 mg/kg/day for 5 days; Neoral) plus high-dose IVIG (2 g/kg for 24 h and aspirin 30 mg/kg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-dose IVIG alone (2 g/kg for 24 h and aspirin 30 mg/kg/day)
Number of subjects: 0
Study: 23800403

Group type: EXPERIMENTAL
Intervention: Esomeprazole 0.5 mg/kg once daily for up to 14 days
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 21968669

Group type: EXPERIMENTAL
Intervention: rosacea treatment system (RTS)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: RTS minus metronidazole (RTS‐M)
Number of subjects: 30

Group type: COMPARATOR
Intervention: metronidazole 0.75% gel plus standard skin care (M+SSC)
Number of subjects: 30
Study: 18446086

Group type: EXPERIMENTAL
Intervention: Current intrauterine device users
Number of subjects: 5829

Group type: COMPARATOR
Intervention: Hormonal contraceptives or condom users
Number of subjects: 5829

Group type: COMPARATOR
Intervention: Women with miscarriages
Number of subjects: 5829

Group type: EXPERIMENTAL
Intervention: Current regular smoking
Number of subjects: 5829

Group type: EXPERIMENTAL
Intervention: Ct positive women
Number of subjects: 5829
Study: 16163443

Group type: EXPERIMENTAL
Intervention: Triamcinolon acetonide 40 mg/ml plus lidocaine 2%
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lidocaine 1% (placebo)
Number of subjects: 20
Study: 12775743

Group type: EXPERIMENTAL
Intervention: Non-English-speaking Latino parents
Number of subjects: 108

Group type: COMPARATOR
Intervention: English-speaking minority parents
Number of subjects: 108

Group type: COMPARATOR
Intervention: English-speaking majority (white) parents
Number of subjects: 108
Study: 10962750

Group type: EXPERIMENTAL
Intervention: DDD pacing at 150 beats/min
Number of subjects: 26

Group type: COMPARATOR
Intervention: DDDR pacing at 175 beats/min
Number of subjects: 26
Study: 9099291

Group type: EXPERIMENTAL
Intervention: LCM 1110
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 352

Group type: COMPARATOR
Intervention: Diclofenac
Number of subjects: 352
Study: 8472154

Group type: EXPERIMENTAL
Intervention: Transhiatal oesophagectomy
Number of subjects: 67

Group type: COMPARATOR
Intervention: Thoracotomy
Number of subjects: 67
Study: 2951805

Group type: EXPERIMENTAL
Intervention: Duovent (80 micrograms ipratropium bromide + 200 micrograms fenoterol)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: fenoterol (400 micrograms)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: salbutamol (200 micrograms)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: disodium cromoglycate (DSCG) (10 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 30986148

Group type: EXPERIMENTAL
Intervention: Animated symbol condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Static symbol condition
Number of subjects: 0
Study: 29183178

Group type: EXPERIMENTAL
Intervention: Communication skills training for health providers
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual care controls
Number of subjects: 240
Study: 26766141

Group type: EXPERIMENTAL
Intervention: mongersen 40 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: mongersen 160 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: mongersen 10 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: mongersen (all doses)
Number of subjects: 0
Study: 25369357

Group type: EXPERIMENTAL
Intervention: Long Acting Reversible Contraception (LARC) methods
Number of subjects: 65
Study: 22594467

Group type: EXPERIMENTAL
Intervention: Clonidine 3-4 μg kg(‐1) (C4)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Clonidine 7-8 μg kg(‐1) (C7)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 60
Study: 19859698

Group type: COMPARATOR
Intervention: Intramuscular morphine (0 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intramuscular morphine (5 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intramuscular morphine (10 mg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Intramuscular morphine (5 mg and 10 mg)
Number of subjects: 18
Study: 18022350

Group type: EXPERIMENTAL
Intervention: Lignocaine (0.2 mL without vasoconstrictor)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Normal saline (0.2 mL)
Number of subjects: 51
Study: 15022521

Group type: EXPERIMENTAL
Intervention: Dental hygienists
Number of subjects: 87

Group type: COMPARATOR
Intervention: Non-dental hygienists
Number of subjects: 87
Study: 11079810

Group type: EXPERIMENTAL
Intervention: 0.2 U/kg x d ultralente insulin
Number of subjects: 14
Study: 9088673

Group type: EXPERIMENTAL
Intervention: Pulse oximetry recordings
Number of subjects: 0
Study: 8224280

Group type: EXPERIMENTAL
Intervention: Deep fundal transfer technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Midfundal transfer technique
Number of subjects: 0
Study: 3899049

Group type: EXPERIMENTAL
Intervention: Hospitalization with family intervention
Number of subjects: 144

Group type: COMPARATOR
Intervention: Hospitalization without family intervention
Number of subjects: 144
Study: 30370439

Group type: EXPERIMENTAL
Intervention: Kinematically aligned TKA
Number of subjects: 14

Group type: COMPARATOR
Intervention: Mechanically aligned TKA
Number of subjects: 14
Study: 28429081

Group type: EXPERIMENTAL
Intervention: Purple grape juice
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sugar-matched control
Number of subjects: 20
Study: 25842051

Group type: EXPERIMENTAL
Intervention: Virtual reality-based balance exercises (n=35)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conventional balance exercises (n=36)
Number of subjects: 71
Study: 23800194

Group type: EXPERIMENTAL
Intervention: Emergency Obstetric and Newborn Care (EmONC) package including clean delivery kit, emollient, chlorhexidine, and training of health care providers.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care (control arm).
Number of subjects: 0
Study: 20881844

Group type: EXPERIMENTAL
Intervention: Paliperidone ER 12 mg/day
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Paliperidone ER 18 mg/day
Number of subjects: 109

Group type: COMPARATOR
Intervention: Quetiapine 800 mg/day
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Paliperidone ER
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 109
Study: 19376787

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg kg(‐1)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Rocuronium 1.0 mg kg(‐1)
Number of subjects: 201
Study: 17680196

Group type: EXPERIMENTAL
Intervention: Psoas compartment block
Number of subjects: 68

Group type: COMPARATOR
Intervention: Femoral nerve block
Number of subjects: 68
Study: 15151527

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil (4 mg day(‐1))
Number of subjects: 8

Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 8
Study: 10886043

Group type: EXPERIMENTAL
Intervention: Naproxen for 8 weeks in H. pylori-positive patients
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Naproxen for 8 weeks in non-infected patients
Number of subjects: 55

Group type: COMPARATOR
Intervention: Anti-Helicobacter therapy in controls (D)
Number of subjects: 55
Study: 9188352

Group type: EXPERIMENTAL
Intervention: Stress management workshops
Number of subjects: 99

Group type: COMPARATOR
Intervention: No-treatment controls
Number of subjects: 99
Study: 1531719

Group type: EXPERIMENTAL
Intervention: Low-dose, intradermal hepatitis B vaccination (2 micrograms)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Booster dose of 2 micrograms i.d.
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Low-dose, intradermal hepatitis B vaccination (3 doses at 0, 1, and 6 months)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Low-dose, intradermal hepatitis B vaccination (2 doses)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Booster dose of 2 micrograms i.d. at month 25
Number of subjects: 88
Study: 3893444

Group type: EXPERIMENTAL
Intervention: suprofen 200 mg
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: pentazocine 30 mg
Number of subjects: 88

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 88
Study: 31425224

Group type: EXPERIMENTAL
Intervention: Thermosoftening of the endotracheal tube (ETT)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (non-thermosoftened ETT)
Number of subjects: 140
Study: 29605722

Group type: EXPERIMENTAL
Intervention: EUS-guided biliary drainage (EUS-BD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: ERCP-guided biliary drainage (ERCP-BD)
Number of subjects: 30
Study: 26996595

Group type: EXPERIMENTAL
Intervention: HDR (7 Gy each in three fractions, repeated weekly)
Number of subjects: 37

Group type: COMPARATOR
Intervention: PDR (70 cGy hourly pulses for 39 hours, total 27 Gy)
Number of subjects: 37
Study: 24820395

Group type: EXPERIMENTAL
Intervention: CBFV (Vm, Vs, Vd, rVm) measured at 18 hours post-CPB
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CBFV (Vs, rVm) measured at 18 hours post-CPB
Number of subjects: 100
Study: 23732307

Group type: EXPERIMENTAL
Intervention: 20 mg of laninamivir octanoate once daily for 2 days (LO-2)
Number of subjects: 1711

Group type: EXPERIMENTAL
Intervention: 20 mg of laninamivir octanoate once daily for 3 days (LO-3)
Number of subjects: 1711

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1711
Study: 20521635

Group type: EXPERIMENTAL
Intervention: Antigenic cartography analysis of avian H5N1 viruses using hemagglutination inhibition (HI) assay.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Characterization of antigenic properties using mammalian or avian antisera.
Number of subjects: 0
Study: 18983547

Group type: EXPERIMENTAL
Intervention: Square-edge hydrophobic acrylic IOL (Acrysof SA 60 AT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Square-edge single-piece PMMA lens (Aurolab SQ 3600)
Number of subjects: 32
Study: 16640685

Group type: EXPERIMENTAL
Intervention: En bloc excision of proximal nail fold with nail plate avulsion (Group II)
Number of subjects: 30

Group type: COMPARATOR
Intervention: En bloc excision of proximal nail fold without nail plate avulsion (Group I)
Number of subjects: 30
Study: 12862326

Group type: EXPERIMENTAL
Intervention: Acute caffeine consumption (5 mg x kg(‐1) body mass)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Chronic caffeine consumption (5 mg x kg(‐1) body mass for 7 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 16
Study: 10974962

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural family intervention
Number of subjects: 0
Study: 8998022

Group type: EXPERIMENTAL
Intervention: Partners in Patient Care (PIPC) nursing care delivery model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control nursing units
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pilot nursing units
Number of subjects: 0
Study: 1595423

Group type: EXPERIMENTAL
Intervention: 20 mg oral d-amphetamine
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31254046

Group type: EXPERIMENTAL
Intervention: Single pelvic floor muscle exercise instruction session supervised by a physical therapist and educational brochures about home-based PFME exercises.
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 202
Study: 31340232

Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg oral midazolam (first session)
Number of subjects: 18

Group type: COMPARATOR
Intervention: oral placebo (first session)
Number of subjects: 18
Study: 27926633

Group type: EXPERIMENTAL
Intervention: Calcium+Vitamin D
Number of subjects: 1521

Group type: EXPERIMENTAL
Intervention: Hormone Therapy
Number of subjects: 1521

Group type: EXPERIMENTAL
Intervention: Calcium+Vitamin D + Hormone Therapy
Number of subjects: 1521

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1521
Study: 26023217

Group type: EXPERIMENTAL
Intervention: Soft tissue massage and exercise (n=40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Exercise only (n=40)
Number of subjects: 80
Study: 23649576

Group type: EXPERIMENTAL
Intervention: Cheese
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Milk
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yogurt
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paraffin (Control)
Number of subjects: 0
Study: 21074974

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Supportive Therapy
Number of subjects: 51
Study: 19556262

Group type: EXPERIMENTAL
Intervention: Prednisone 1 mg kg(‐1) day(‐1) for 4 weeks followed by 0.33 mg kg(‐1) day(‐1) for 5 months and azathioprine 2 mg kg(‐1) day(‐1) for 6 months (Group 1)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo (Group 2)
Number of subjects: 85
Study: 17541639

Group type: EXPERIMENTAL
Intervention: MMRV vaccine co-administered with DTPa-HBV-IPV/Hib vaccine
Number of subjects: 451

Group type: COMPARATOR
Intervention: MMRV vaccine alone
Number of subjects: 451

Group type: COMPARATOR
Intervention: Booster dose of DTPa-HBV-IPV/Hib vaccine
Number of subjects: 451
Study: 15579570

Group type: EXPERIMENTAL
Intervention: Prior heavy-intensity warm-up exercise (Mod2)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Moderate-intensity exercise without prior warm-up (Mod1)
Number of subjects: 12
Study: 12109633

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/d
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 10390000

Group type: EXPERIMENTAL
Intervention: Oral pamidronate
Number of subjects: 37
Study: 7491293

Group type: EXPERIMENTAL
Intervention: Carotenoid vegetable diet (carrot and spinach)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cruciferous vegetable diet (broccoli and cauliflower)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Soy diet (tofu and textured vegetable protein product)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Basal diet (vegetable free)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Other test diets (carotenoid and cruciferous)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Gender comparison
Number of subjects: 20
Study: 2112943

Group type: EXPERIMENTAL
Intervention: Three minutes of tidal breathing from a Magill breathing system
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Four vital capacity breaths from a non‐rebreathing system
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Four vital capacity breaths from a Magill breathing system
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Maximal expiration before application of the face mask with four vital capacity breaths from a Magill system
Number of subjects: 20
Study: 419454

Group type: EXPERIMENTAL
Intervention: Ringer's Lactate (RL)
Number of subjects: 29

Group type: COMPARATOR
Intervention: 5% albumin in Ringer's lactate (ALB)
Number of subjects: 29
Study: 30509941

Group type: EXPERIMENTAL
Intervention: Serial blood sampling and duplex real‐time quantitative PCR (qPCR)
Number of subjects: 771

Group type: EXPERIMENTAL
Intervention: Benznidazole arm
Number of subjects: 771

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 771
Study: 28049201

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral adherence promotion program (2 sessions)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 33
Study: 25998003

Group type: EXPERIMENTAL
Intervention: Super Flex punctal plugs
Number of subjects: 50

Group type: COMPARATOR
Intervention: Parasol punctal plugs
Number of subjects: 50
Study: 23142309

Group type: EXPERIMENTAL
Intervention: Pelargonium sidoides daily for 5 days (n=30)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (no treatment, n=31)
Number of subjects: 61
Study: 21727781

Group type: EXPERIMENTAL
Intervention: Real rTMS
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 33
Study: 19786405

Group type: EXPERIMENTAL
Intervention: Avanta/Sutter MCP prostheses
Number of subjects: 18

Group type: COMPARATOR
Intervention: Swanson MCP prostheses
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 18
Study: 16713009

Group type: EXPERIMENTAL
Intervention: valsartan 80 mg/day for 12 weeks
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control (not administered valsartan)
Number of subjects: 55
Study: 14716700

Group type: EXPERIMENTAL
Intervention: Donepezil (up to 10 mg once daily)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Galantamine (up to 12 mg twice daily)
Number of subjects: 120
Study: 11747380

Group type: EXPERIMENTAL
Intervention: DASH diet with lower sodium intake
Number of subjects: 412

Group type: COMPARATOR
Intervention: Control (typical U.S. diet) with lower sodium intake
Number of subjects: 412
Study: 9252210

Group type: EXPERIMENTAL
Intervention: Senna
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Wheat bran (mean intake 19.8 g day(-1))
Number of subjects: 40

Group type: COMPARATOR
Intervention: Loperamide
Number of subjects: 40
Study: 8277143

Group type: EXPERIMENTAL
Intervention: Fluoxetine, 20 mg/day
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 3325229

Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate (20 mg) - Group M2 (2 tablets per day)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate (20 mg) - Group M3 (3 tablets per day)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Isosorbide dinitrate retard (40 mg) - Group D2 (2 tablets per day)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Isosorbide dinitrate retard (40 mg) - Group D3 (3 tablets per day)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate (20 mg)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Isosorbide dinitrate retard (40 mg)
Number of subjects: 200
Study: 29228079

Group type: EXPERIMENTAL
Intervention: High-intensity treadmill exercise (4 days per week, 80%-85% maximum heart rate)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Moderate-intensity treadmill exercise (4 days per week, 60%-65% maximum heart rate)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 128
Study: 27002933

Group type: COMPARATOR
Intervention: Incremental protocol
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Decremental protocol
Number of subjects: 19
Study: 23906445

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg/day
Number of subjects: 182

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 182
Study: 23796693

Group type: EXPERIMENTAL
Intervention: Micronutrient-fortified sorghum meal (n = 67)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control (n = 65)
Number of subjects: 132